eHealth, Inc. (EHTH)
USD 8.09
(5.06%)
USD 8.09
(5.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.69 Million | -26.86 Million | -162.62 Million | -107.86 Million | -71.49 Million | -3.23 Million |
| Net Income | -28.21 Million | -88.72 Million | -104.37 Million | 45.45 Million | 66.88 Million | 241 Thousand |
| Depreciation & Amortization | 19.91 Million | 21.1 Million | 18.86 Million | 12.94 Million | 8.99 Million | 6.77 Million |
| Deferred income taxes | -2.67 Million | -18.43 Million | -21.52 Million | 8.81 Million | 16.19 Million | 2.81 Million |
| Stock-based compensation | 23.21 Million | 20.31 Million | 32.85 Million | 25.17 Million | 22.57 Million | 12.54 Million |
| Change in working capital | -19.63 Million | 24.67 Million | -136.25 Million | -201.33 Million | -209.46 Million | -38.56 Million |
| Other non-cash items | 701 Thousand | 14.18 Million | 47.81 Million | 1.09 Million | 23.32 Million | 12.97 Million |
| Investing Cash Flow | -15.89 Million | 25.86 Million | -12.63 Million | -73.28 Million | -16.94 Million | -25.75 Million |
| Investments in PPE | -10.77 Million | -15.5 Million | -20.85 Million | -23.75 Million | -16.87 Million | -10.82 Million |
| Acquisitions | 10.77 Million | 15.5 Million | 16.99 Million | 16 Million | - | -14.92 Million |
| Investment purchases | -54.51 Million | -8.4 Million | -103.05 Million | -180.5 Million | - | - |
| Sales/Maturities of investments | 49.4 Million | 49.76 Million | 111.28 Million | 130.97 Million | - | - |
| Other Investing Activities | -10.77 Million | -15.5 Million | -16.99 Million | -16 Million | -72 Thousand | -6.29 Million |
| Financing Cash Flow | -6.22 Million | 63.83 Million | 213.24 Million | 201.24 Million | 102.14 Million | 1.86 Million |
| Debt repayment | -38 Thousand | -136 Thousand | -150 Thousand | -157 Thousand | -5.1 Million | -103 Thousand |
| Dividends payments | -3.53 Million | - | - | - | - | - |
| Common Stock Repurchased | -3.33 Million | -3.1 Million | -9.33 Million | -19.8 Million | -14.28 Million | -4.5 Million |
| Common Stock Issuance | 677 Thousand | 2.21 Million | 214.02 Million | 228.02 Million | 126.05 Million | 2.68 Million |
| Other Financing Activities | -2.69 Million | 64.86 Million | 222.72 Million | -4.86 Million | 1.01 Million | 6.46 Million |
| Accounts receivables | -34.95 Million | 3.11 Million | -3.95 Million | 533 Thousand | 1.27 Million | -2.12 Million |
| Accounts payables | 487 Thousand | -7.02 Million | -23.05 Million | 12.29 Million | 19.69 Million | 1.41 Million |
| Inventory | - | - | -105.19 Million | -202.86 Million | -240.93 Million | -43.48 Million |
| Other working capital | 14.83 Million | 28.59 Million | -4.06 Million | -11.29 Million | 10.5 Million | 5.62 Million |
| Cash at beginning of period | 144.4 Million | 85.16 Million | 47.11 Million | 26.82 Million | 13.08 Million | 40.29 Million |
| Cash at end of period | 115.72 Million | 147.64 Million | 85.16 Million | 47.11 Million | 26.82 Million | 13.08 Million |
| Capital Expenditure | -10.77 Million | -15.5 Million | -20.85 Million | -23.75 Million | -16.87 Million | -10.82 Million |
| Effect of forex changes on cash | -19 Thousand | -355 Thousand | 64 Thousand | 187 Thousand | 26 Thousand | -77 Thousand |
| Net cash flow / Change in cash | -28.67 Million | 62.47 Million | 38.05 Million | 20.29 Million | 13.73 Million | -27.2 Million |
| Free Cash Flow | -17.47 Million | -42.37 Million | -183.47 Million | -131.61 Million | -88.36 Million | -14.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -27.96 Million | -16.98 Million | 52.19 Million | -28.21 Million | -37.02 Million | -23.5 Million |
| Depreciation & Amortization | 4.27 Million | 4.4 Million | 4.77 Million | 19.91 Million | 4.74 Million | 5.15 Million |
| Deferred income taxes | -1.24 Million | -1.38 Million | 6.63 Million | -2.67 Million | -2.61 Million | -3.08 Million |
| Stock-based compensation | 5.1 Million | 5.54 Million | 5.47 Million | 23.21 Million | 6.55 Million | 6.19 Million |
| Change in working capital | -14.22 Million | 73.76 Million | -103.15 Million | -19.63 Million | 3.55 Million | 5.98 Million |
| Other non-cash items | 2 Million | -54.97 Million | 696 Thousand | 701 Thousand | 106 Thousand | -162 Thousand |
| Investing Cash Flow | -13.44 Million | -10.28 Million | 596 Thousand | -15.89 Million | 24.28 Million | -16.53 Million |
| Investments in PPE | -2.85 Million | -2.49 Million | -1.99 Million | -10.77 Million | -4.21 Million | -2.34 Million |
| Acquisitions | - | - | 1.99 Million | 10.77 Million | - | 2.03 Million |
| Investment purchases | -23.59 Million | -13.79 Million | -5.91 Million | -54.51 Million | - | -26.59 Million |
| Sales/Maturities of investments | 13 Million | 6 Million | 8.5 Million | 49.4 Million | 28.5 Million | 12.4 Million |
| Other Investing Activities | -13.18 Million | -2.49 Million | -1.99 Million | -10.77 Million | 25.67 Million | -2.03 Million |
| Financing Cash Flow | -2.98 Million | -1.25 Million | -3.64 Million | -6.22 Million | -892 Thousand | -1.24 Million |
| Debt repayment | - | -4000.00 | -5000.00 | -38 Thousand | -8000.00 | -14 Thousand |
| Dividends payments | -2.74 Million | - | -2.66 Million | -3.53 Million | - | -873 Thousand |
| Common Stock Repurchased | -596 Thousand | -1.25 Million | -1.39 Million | -3.33 Million | -884 Thousand | -623 Thousand |
| Common Stock Issuance | 354 Thousand | - | 415 Thousand | 677 Thousand | - | 262 Thousand |
| Other Financing Activities | 354 Thousand | -1.25 Million | -985 Thousand | -2.69 Million | -8000.00 | -375 Thousand |
| Accounts receivables | 13.82 Million | 75.68 Million | -141.22 Million | -34.95 Million | 121 Thousand | 384 Thousand |
| Accounts payables | -1.53 Million | -937 Thousand | 306 Thousand | 487 Thousand | 802 Thousand | 872 Thousand |
| Inventory | - | - | -6.74 Million | - | -4.23 Million | 10.98 Million |
| Other working capital | -26.51 Million | -980 Thousand | 37.76 Million | 14.83 Million | 6.86 Million | -6.25 Million |
| Cash at beginning of period | 174.98 Million | 115.72 Million | 152.11 Million | 144.4 Million | 156.42 Million | 183.87 Million |
| Cash at end of period | 126.34 Million | 174.98 Million | 115.72 Million | 115.72 Million | 155.2 Million | 156.42 Million |
| Capital Expenditure | -2.85 Million | -2.49 Million | -1.99 Million | -10.77 Million | -4.21 Million | -2.34 Million |
| Effect of forex changes on cash | -30 Thousand | 49 Thousand | 39 Thousand | -19 Thousand | 69 Thousand | -235 Thousand |
| Net cash flow / Change in cash | -48.64 Million | 59.26 Million | -36.39 Million | -28.67 Million | -1.21 Million | -27.44 Million |
| Free Cash Flow | -35.03 Million | 68.27 Million | -35.37 Million | -17.47 Million | -28.89 Million | -11.77 Million |
INDR
ASTH
ALCOX
BCH-R
OGFGF
2017